Broughton

Activities: Manufacturing Regulatory Drug Delivery Research & Development

Helping you deliver life-enhancing products to market through analytical testing excellence integrated with best-in-class scientific consultancy and regulatory compliance

Trending Articles

  1. The new F-Gas Regulation and its impact on pharmaceutical freeze-drying Freeze-drying or lyophilization represents a pivotal process in the life sciences industry. During the past five decades, the technology involved has evolved into a complex,...
  2. Quantoom Biosciences, Univercells and Fiocruz collaborate to advance global RNA vaccine development Together, the companies will develop RNA-based biopharmaceuticals, while also building a dedicated mRNA production facility in Brazil
  3. Gerresheimer begins €100m expansion of its pharmaceutical syringe production capabilities The extension of its Skopje, North Macedonia site will allow Gerresheimer to better serve the pharmaceutical and biotech industries
  4. Ipsen licenses Biomunex Pharmaceuticals' bispecific antibody, BMX-502 The deal makes Biomunex eligible for up to $610m, with Ipsen being responsible for getting the cancer immunotherapy into Phase I clinical trials
  5. Europa Biosite acquires life science product and service supplier, AMSBIO Europa Biosite will now be able to expand its presence across the key US market, while also bolstering its offerings in stem cell research, regenerative medicine and biospecimens

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Regulatory

Stability testing for pMDIs

To comply with the necessary regulations in the UK and other jurisdictions, stability testing is a crucial part of inhaler quality assurance. However, these extensive studies can take up time, space and valuable resources
Regulatory

Broughton bolsters medicinal cannabis batch testing capabilities

The company will offer a range of macro and microscopic analytic techniques, assuring the quality of cannabis for the medical market
Regulatory

Broughton receives Schedule 1 controlled drugs licence

Licence extends Broughton’s handling and testing of cannabis materials
Regulatory

Broughton receives flexible scope ISO 17025 accreditation

New certification allows accreditation without prior approval
Research & Development

Celebrating women in science: the toxicologist

To recognise International Women’s Day 2024, Cristelle Santos, Consultant Toxicologist at Broughton, shares her experiences as a toxicologist to inspire more people to enter the field
Ingredients

Does CBD really harm the liver?

With the exception of certain approved drugs such, as Epidiolex and Sativex, the US Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) have voiced concerns about CBD-containing products being made available on the market
Research & Development

Stability testing: on trend

A stability study is a large body of work that is resource, time, and space intensive
Subscribe now